Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Virology. 2007 Mar 9;363(2):310–318. doi: 10.1016/j.virol.2007.02.002

Fig. 1.

Fig. 1

Infection of sMAGI cells and human MAGI-CCR5 across a range of virus doses. The number of blue, β-galactosidase positive cells was determined using microscopy to count blue cell foci, which has an upper range or reliable quantification at ~1000 blue cells. The X-axis represents increasing infectious dose of virus as defined by Gagp24 (or Gagp27 for SIV) concentration. Error bars represent standard deviation of three replicate infections. The average number of blue cells detected in mock-infected cells was subtracted from each data point. Hollow symbols represent the number of infected rhesus sMAGI cells; black solid symbols represent the number of infected human MAGI-CCR5 cells. A. Infection with HIV-1/SF162. B. Infection with HIV-1/VSV-G. C. Infection with SIV/VSV-G. D. Infections with HIV-1/VSV-G (square symbols) and SIV/VSV-G (circle symbols) in the presence of HIV-1 VLP with a VSV-G envelope (left panel) or HIV-1 VLP lacking envelope (right panel).